Condensed Statements of Cash Flows - USD ($)	3 Months Ended	4 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 1,189,699	$ (3,553)	$ 1,189,699
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in FV of warrant liability	(1,451,250)		(1,451,250)
Interest earned on marketable securities held in Trust Account	(261,996)		(261,996)
Changes in operating assets and liabilities:
Other assets			(968,777)
Accounts payable and accrued expenses			286,221
Accrued offering expenses		3,553
Due to sponsor			(269,490)
Net cash used in operating activities			(1,475,593)
Cash Flows from Investing Activities:
Investment of cash into Trust Account			(266,512,500)
Net cash used in investing activities			(266,512,500)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid			253,575,000
Proceeds from sale of private placements warrants.			16,087,500
Advances from Sponsor			25,000
Payment of offering costs			(469,891)
Net cash provided by financing activities			269,217,609
Net Change in Cash			1,229,516
Cash - End of period	$ 1,229,516		1,229,516
Non-cash investing and financing activities:
Deferred offering costs included in accrued offering expenses		35,000
Deferred offering costs paid through Due to Sponsor		289,902	$ 325,765
Deferred offering costs paid by sponsor in exchange for issuance of Class B ordinary shares		15,000
Issuance of Class B ordinary shares subscription receivable		$ 10,000